AACR Journals
@aacrjournals.bsky.social
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
Look back at the AACR Journals 2025!
Veronika Lutz, PhD and Christian Bauer, MD received the 2025 Cancer Immunology Research Award for Outstanding Journal Article at the AACR Journals Reception.
⏯️Watch their interview describing their study: buff.ly/UkqKeLK
Veronika Lutz, PhD and Christian Bauer, MD received the 2025 Cancer Immunology Research Award for Outstanding Journal Article at the AACR Journals Reception.
⏯️Watch their interview describing their study: buff.ly/UkqKeLK
December 12, 2025 at 10:43 PM
Look back at the AACR Journals 2025!
Veronika Lutz, PhD and Christian Bauer, MD received the 2025 Cancer Immunology Research Award for Outstanding Journal Article at the AACR Journals Reception.
⏯️Watch their interview describing their study: buff.ly/UkqKeLK
Veronika Lutz, PhD and Christian Bauer, MD received the 2025 Cancer Immunology Research Award for Outstanding Journal Article at the AACR Journals Reception.
⏯️Watch their interview describing their study: buff.ly/UkqKeLK
In this Cancer Immunology Research article, the authors report the characterization of a tumor-selective bispecific antibody that conditionally costimulates T cells via CD28 in a pH- and VISTA-dependent manner.
Read more: CD28xVISTA Bispecifics for Conditional T-cell Costimulation buff.ly/765agfk
Read more: CD28xVISTA Bispecifics for Conditional T-cell Costimulation buff.ly/765agfk
December 12, 2025 at 5:03 PM
In this Cancer Immunology Research article, the authors report the characterization of a tumor-selective bispecific antibody that conditionally costimulates T cells via CD28 in a pH- and VISTA-dependent manner.
Read more: CD28xVISTA Bispecifics for Conditional T-cell Costimulation buff.ly/765agfk
Read more: CD28xVISTA Bispecifics for Conditional T-cell Costimulation buff.ly/765agfk
I-Mei Siu, PhD, Senior Editor for Cancer Discovery is attending @theaacr.bsky.social Conference on The Rise in Early-Onset Cancers. If you have a question about the journal or are interested in discussing your research, reach out to her at [email protected]. @i-mei.bsky.social #AACRearlyonset25
December 12, 2025 at 2:03 PM
I-Mei Siu, PhD, Senior Editor for Cancer Discovery is attending @theaacr.bsky.social Conference on The Rise in Early-Onset Cancers. If you have a question about the journal or are interested in discussing your research, reach out to her at [email protected]. @i-mei.bsky.social #AACRearlyonset25
Look back at the AACR Journals 2025!
Moray Campbell and colleagues received the Cancer Research Communications Award for Outstanding Journal Article. The authors are pictured with Editor-in-Chief Elaine Mardis after receiving their award.
▶️ Learn more: buff.ly/lQOCJIT
Moray Campbell and colleagues received the Cancer Research Communications Award for Outstanding Journal Article. The authors are pictured with Editor-in-Chief Elaine Mardis after receiving their award.
▶️ Learn more: buff.ly/lQOCJIT
December 11, 2025 at 10:41 PM
Look back at the AACR Journals 2025!
Moray Campbell and colleagues received the Cancer Research Communications Award for Outstanding Journal Article. The authors are pictured with Editor-in-Chief Elaine Mardis after receiving their award.
▶️ Learn more: buff.ly/lQOCJIT
Moray Campbell and colleagues received the Cancer Research Communications Award for Outstanding Journal Article. The authors are pictured with Editor-in-Chief Elaine Mardis after receiving their award.
▶️ Learn more: buff.ly/lQOCJIT
The January 9 submission deadline is fast approaching!
Have a question about the nomination process for this year's Clinical Cancer Research Early Career Award?
Contact us at [email protected]. buff.ly/ybilkEx
Have a question about the nomination process for this year's Clinical Cancer Research Early Career Award?
Contact us at [email protected]. buff.ly/ybilkEx
December 11, 2025 at 5:04 PM
The January 9 submission deadline is fast approaching!
Have a question about the nomination process for this year's Clinical Cancer Research Early Career Award?
Contact us at [email protected]. buff.ly/ybilkEx
Have a question about the nomination process for this year's Clinical Cancer Research Early Career Award?
Contact us at [email protected]. buff.ly/ybilkEx
Read the article in Cancer Research: Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells doi.org/10.1158/0008...
[Research] 🧠 First real-time footage of brain immune cells battling cancer seed cells captured! By blocking two "don't eat me" proteins (CD24 & CD47), brain tumor formation is decreased. Early intervention (first ~12 days) identified as critical. @aacrjournals.bsky.social bit.ly/4pGG9pd 🧪
Study captures how cancer cells hide from brain immune cells, shows that removing their “don’t eat me” signals stops their escape. | News & Events | Nagoya University
Stay informed about research breakthroughs, university announcements, and opportunities to engage with Nagoya University's dynamic global community.
bit.ly
December 11, 2025 at 4:20 PM
Read the article in Cancer Research: Microglia Display Heterogeneous Initial Responses to Disseminated Tumor Cells doi.org/10.1158/0008...
Adam Scheid, PhD, Associate Editor for Cancer Research Communications, is attending @theaacr.bsky.social Conference on The Rise in Early-Onset Cancers. If you have a question about the journal or are interested in discussing your research, reach out to him at [email protected]. #AACRearlyonset25
December 11, 2025 at 2:55 PM
Adam Scheid, PhD, Associate Editor for Cancer Research Communications, is attending @theaacr.bsky.social Conference on The Rise in Early-Onset Cancers. If you have a question about the journal or are interested in discussing your research, reach out to him at [email protected]. #AACRearlyonset25
The Immuno-oncology collection highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. Check it out: buff.ly/L4GpWAx
December 10, 2025 at 11:15 PM
The Immuno-oncology collection highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. Check it out: buff.ly/L4GpWAx
Look back at the AACR Journals 2025!
Cancer Research launched a special series to provide a platform for disseminating high-quality research and reviews on the frontier of computational and data-driven approaches in cancer research.
Cancer Research launched a special series to provide a platform for disseminating high-quality research and reviews on the frontier of computational and data-driven approaches in cancer research.
December 10, 2025 at 5:02 PM
Look back at the AACR Journals 2025!
Cancer Research launched a special series to provide a platform for disseminating high-quality research and reviews on the frontier of computational and data-driven approaches in cancer research.
Cancer Research launched a special series to provide a platform for disseminating high-quality research and reviews on the frontier of computational and data-driven approaches in cancer research.
Earlier this year, we interviewed Timothy A. Yap, Clinical Cancer Research Editor-in-Chief.
In this clip, Dr. Yap discusses the types of clinical studies and translational data ripe for publishing in the Journal.
Learn More: buff.ly/OA1rEAg
In this clip, Dr. Yap discusses the types of clinical studies and translational data ripe for publishing in the Journal.
Learn More: buff.ly/OA1rEAg
December 9, 2025 at 10:10 PM
Earlier this year, we interviewed Timothy A. Yap, Clinical Cancer Research Editor-in-Chief.
In this clip, Dr. Yap discusses the types of clinical studies and translational data ripe for publishing in the Journal.
Learn More: buff.ly/OA1rEAg
In this clip, Dr. Yap discusses the types of clinical studies and translational data ripe for publishing in the Journal.
Learn More: buff.ly/OA1rEAg
Reposted by AACR Journals
Research from Dr. Peter Glazer shows how tumor hypoxia shuts down the STING pathway, dampening immune responses. Inhibiting KDM1A reverses this effect, restores STING activity + could improve efficacy of cancer therapy.
aacrjournals.org/cancerres/ar...
@aacrjournals.bsky.social
aacrjournals.org/cancerres/ar...
@aacrjournals.bsky.social
Hypoxia Induces Immunosuppression by Silencing STING in Cancer
Hypoxia silences STING expression in a HIF1α–dependent manner that is mediated by KDM1A/KDM5A and oncometabolites, which can be reversed by targeting KDM1A as a potential strategy for enhancing cancer...
aacrjournals.org
December 4, 2025 at 8:11 PM
Research from Dr. Peter Glazer shows how tumor hypoxia shuts down the STING pathway, dampening immune responses. Inhibiting KDM1A reverses this effect, restores STING activity + could improve efficacy of cancer therapy.
aacrjournals.org/cancerres/ar...
@aacrjournals.bsky.social
aacrjournals.org/cancerres/ar...
@aacrjournals.bsky.social
The January 9 submission deadline is fast approaching! ⏰
Have a question about the nomination process for this year's Cancer Research Early Career Award?
✉️ Contact us at [email protected]. buff.ly/QMkGmGl
Have a question about the nomination process for this year's Cancer Research Early Career Award?
✉️ Contact us at [email protected]. buff.ly/QMkGmGl
December 9, 2025 at 5:04 PM
The January 9 submission deadline is fast approaching! ⏰
Have a question about the nomination process for this year's Cancer Research Early Career Award?
✉️ Contact us at [email protected]. buff.ly/QMkGmGl
Have a question about the nomination process for this year's Cancer Research Early Career Award?
✉️ Contact us at [email protected]. buff.ly/QMkGmGl
Read the Acute Leukemia collection of articles, highlighting recent advances on mechanisms of pathogenesis, therapeutic approaches, and molecular determinants of clinical response and resistance: buff.ly/Qazc0io #ASH25
December 9, 2025 at 2:16 PM
Read the Acute Leukemia collection of articles, highlighting recent advances on mechanisms of pathogenesis, therapeutic approaches, and molecular determinants of clinical response and resistance: buff.ly/Qazc0io #ASH25
Attending #ASH25? Read the Myeloma article collection: buff.ly/07bCWHv
December 8, 2025 at 10:43 PM
Attending #ASH25? Read the Myeloma article collection: buff.ly/07bCWHv
Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques, uncovering molecular networks that drive oncogenesis and progression, and bringing innovative therapies to patients. buff.ly/q3NmZc2
December 8, 2025 at 10:07 PM
Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques, uncovering molecular networks that drive oncogenesis and progression, and bringing innovative therapies to patients. buff.ly/q3NmZc2
Join Tanya Bondar, PhD, Deputy Editor of Blood Cancer Discovery, at AACR booth 2103 from 1:00 – 2:00 PM today to learn about publishing your research in the Journal. #ASH25 @tanyabondar.bsky.social
December 8, 2025 at 5:03 PM
Join Tanya Bondar, PhD, Deputy Editor of Blood Cancer Discovery, at AACR booth 2103 from 1:00 – 2:00 PM today to learn about publishing your research in the Journal. #ASH25 @tanyabondar.bsky.social
🕰️ The January 9 submission deadline is fast approaching!
Have a question about the nomination process for this year's Cancer Discovery Early Career Award?
▶️ Contact us at [email protected]. buff.ly/jUwZsdd
Have a question about the nomination process for this year's Cancer Discovery Early Career Award?
▶️ Contact us at [email protected]. buff.ly/jUwZsdd
December 8, 2025 at 2:33 PM
🕰️ The January 9 submission deadline is fast approaching!
Have a question about the nomination process for this year's Cancer Discovery Early Career Award?
▶️ Contact us at [email protected]. buff.ly/jUwZsdd
Have a question about the nomination process for this year's Cancer Discovery Early Career Award?
▶️ Contact us at [email protected]. buff.ly/jUwZsdd
Read this recently published In Focus article— The Global State of Blood Cancers: An Ongoing Challenge, adapted from the 15th edition of the annual AACR Cancer Progress Report. buff.ly/ttfKgFy #ASH25
December 7, 2025 at 8:32 PM
Read this recently published In Focus article— The Global State of Blood Cancers: An Ongoing Challenge, adapted from the 15th edition of the annual AACR Cancer Progress Report. buff.ly/ttfKgFy #ASH25
Attending #ASH25? Stop by AACR Booth 2103 to pick up a copy of the November issue of Blood Cancer Discovery. Or read online here: buff.ly/4kuuEJ7.
December 7, 2025 at 4:22 PM
Attending #ASH25? Stop by AACR Booth 2103 to pick up a copy of the November issue of Blood Cancer Discovery. Or read online here: buff.ly/4kuuEJ7.
Join Tanya Bondar, PhD, Deputy Editor of Blood Cancer Discovery, at AACR booth 2103 from 12:00 – 1:00 PM today to learn about publishing your research in the Journal. #ASH25 @tanyabondar.bsky.social
December 7, 2025 at 4:00 PM
Join Tanya Bondar, PhD, Deputy Editor of Blood Cancer Discovery, at AACR booth 2103 from 12:00 – 1:00 PM today to learn about publishing your research in the Journal. #ASH25 @tanyabondar.bsky.social
Read the research article in Blood Cancer Discovery, "Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 For Diffuse Large B-Cell Lymphoma" by Zhongying Mo, Antonia Lopez-Girona et al. buff.ly/u3oO13c #ASH25
December 7, 2025 at 2:45 PM
Read the research article in Blood Cancer Discovery, "Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 For Diffuse Large B-Cell Lymphoma" by Zhongying Mo, Antonia Lopez-Girona et al. buff.ly/u3oO13c #ASH25
Dr. Dominique Bonnet is speaking in the New Frontiers in Neutrophil Biology session at #ASH25. Read her related article, now online in Blood Cancer Discovery: Epigenetic and myeloid drivers of TET2mut-CH buff.ly/SBYX5AG
December 6, 2025 at 9:15 PM
Dr. Dominique Bonnet is speaking in the New Frontiers in Neutrophil Biology session at #ASH25. Read her related article, now online in Blood Cancer Discovery: Epigenetic and myeloid drivers of TET2mut-CH buff.ly/SBYX5AG
Tanya Bondar, PhD, Deputy Editor for Blood Cancer Discovery, is attending #ASH25. Contact her at [email protected] to discuss your research and the AACR Journals! @tanyabondar.bsky.social
December 6, 2025 at 4:26 PM
Tanya Bondar, PhD, Deputy Editor for Blood Cancer Discovery, is attending #ASH25. Contact her at [email protected] to discuss your research and the AACR Journals! @tanyabondar.bsky.social
Attending #AACRevol25? Read the Tumor Evolution article collection: buff.ly/MMgIemS
December 6, 2025 at 2:01 PM
Attending #AACRevol25? Read the Tumor Evolution article collection: buff.ly/MMgIemS
Attending #AACRevol25? Don’t miss Plenary Session 5: Co-Evolution of Tumor and Host Metabolism, featuring Molecular Cancer Research’s Editor-in-Chief Massimo Loda, MD.
December 5, 2025 at 7:30 PM
Attending #AACRevol25? Don’t miss Plenary Session 5: Co-Evolution of Tumor and Host Metabolism, featuring Molecular Cancer Research’s Editor-in-Chief Massimo Loda, MD.